(Q37233932)

19 August 2017

1 reference

title

Tigecycline: a critical update (English)

1 reference

19 August 2017

Shakil S

1

1 reference

19 August 2017

Akram M

series ordinal

2

1 reference

19 August 2017

Khan AU

series ordinal

3

1 reference

19 August 2017

publication date

1 August 2008

1 reference

19 August 2017

published in

Journal of Chemotherapy

1 reference

19 August 2017

volume

20

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

411-419

1 reference

Enterococci and streptococci

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline: a novel broad-spectrum antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline: a novel glycylcycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Functional, biophysical, and structural bases for antibacterial activity of tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Rapid development of Acinetobacter baumannii resistance to tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Evidence for low risk of Clostridium difficile infection associated with tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

Tigecycline is modified by the flavin-dependent monooxygenase TetX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2008.20.4.411

10.1179/JOC.2008.20.4.411

21 January 2018

Identifiers

DOI

1 reference

release_7bqnpn5znfcojjgx6rxcvm6uka

19 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7bqnpn5znfcojjgx6rxcvm6uka

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference